Miscellaneous Pharmacologic Treatments of Psoriasis
Customize your policy alerts
Sign up for Premera Bluecross Policy 5.01.652 alerts
Get alerted when Policy 5.01.652 changes without checking for updates manually.
Monitor payer policy activity
This policy governs prior authorization and medical-necessity review for selected topical, injectable, and intravenous treatments for plaque psoriasis and generalized pustular psoriasis for Premera commercial plan members. Site-of-service criteria apply to all plan members except Alaska fully insured members.
HCPCS code J1747 was added for Spevigo (spesolimab-sbzo).
Coverage criteria for Dovonex (calcipotriene) and Soriatane (acitretin) were removed because the products were discontinued.
Spevigo subcutaneous coverage criteria were updated to specify treatment of generalized pustular psoriasis when the individual is not experiencing a flare, weighs at least 40 kg, and has a history of at least two moderate-to-severe generalized pustular psoriasis flares.
Spevigo intravenous criteria were updated to specify a minimum individual weight of 40 kg and reauthorization after prior intravenous treatment for a generalized pustular psoriasis flare with clinical response.
The age requirement for Zoryve (roflumilast) 0.3% cream for plaque psoriasis was reduced from 6 years to 2 years.
The policy clarified that site-of-service medical-necessity criteria may apply to injection drugs.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.